By Professor David Goldstein

Journal articles

Pranavan G; Goldstein D; Yip D, 2009, 'Response of Carney`s triad-related metastatic gastrointestinal stromal tumor to sunitinib', Asia-Pacific Journal of Clinical Oncology, 4, pp. 170 - 174

Phillips P; Yang L; Vonlaufen A; Xu Z; Biankin AV; Goldstein D; Pirola R; Wilson JS; Apte MV, 2009, 'S1820 Heat Shock Proteins Are Induced During Pancreatic Stellate Cell Activation in Pancreatic Cancer', Gastroenterology, 136, pp. A - 277, http://dx.doi.org/10.1016/s0016-5085(09)61262-2

Tan TH; Hemmings C; Stafford-bell M; Robson S; Goldstein D; Yip D, 2009, 'The successful management of two pregnancies with wild type metastatic gastrointestinal stromal tumors', Asia-Pacific Journal of Clinical Oncology, 5, pp. 187 - 192

Goldstein D; Van Hazel GA; Pavlakis N, 2009, 'Treatment of 5-Fluorouracil-Refractory Patients With Liver Metastases From Colorectal Cancer Using Yttrium-90 Resin Microspheres Plus Concomitant Systemic Irinotecan Chemotherapy', Journal of Clinical Oncology, 27, pp. 4085 - 4095

Lee CK; Hadley A; Desilva K; Goldstein D, 2009, 'When is a GIST not a GIST? A case report of synchronous metastatic gastrointestinal stromal tumor and fibromatosis', World Journal of Surgical Oncology, 7, pp. 1 - 4

Alvaro F; Young A; Goldstein D; Thomas D; McJannett M; Dillon R, 2008, 'Clinical oncological society of Australia: Adolescent and young adult cancer forum', Cancer Forum, 32, pp. 116 - 119

Goldstein D; Bennett B; Cameron B; Boyle F; DeSouza P; Wilcken N; Friedlander M; Scott E; Hickie I; Lloyd AAM, 2008, 'A prospective cohort study of fatigue after adjuvant therapy for breast cancer: Association with hematologic, endocrine, and immune parameters', JOURNAL OF CLINICAL ONCOLOGY, 26, http://dx.doi.org/10.1200/jco.2008.26.15_suppl.9596

Blinman PL; Duric VM; Nowak AK; Beale P; Clarke SJ; Briscoe K; Boyce A; Goldstein D; Hudson M; Stockler MR, 2008, 'Patients' preferences for adjuvant chemotherapy (ACT) in early colon cancer (ECC): What makes it worthwhile?', JOURNAL OF CLINICAL ONCOLOGY, 26, http://dx.doi.org/10.1200/jco.2008.26.15_suppl.4050

Spry N; Macleod C; Borg M; Ngan SY; Millar J; Graham PH; Zissiadis Y; Kneebone AB; Carroll SL; Davies T; Reece W; Iacopetta BJ; Goldstein D; Harvey JE, 2008, '3D radiotherapy can be safely combined with sandwich systemic gemcitabine chemotherapy in the management of pancreatic cancer: Factors influencing outcome', International Journal of Radiation Oncology and Biology Physics, 70, pp. 1438 - 1446, http://dx.doi.org/10.1016/j.ijrobp.2007.08.070

Lin CS-Y; Krishnan A; Goldstein D; Friedlander M; Kiernan M, 2008, '457: Sensory nerve excitability in cancer patients treated with oxaliplatin', Journal of Clinical Neuroscience, 15, pp. 362 - 362, http://dx.doi.org/10.1016/j.jocn.2007.07.067

Shepherd LM; Goldstein D; Olver IN; Parle MD, 2008, 'Enhancing psychosocial care for people with cancer in rural communities: what can remote counselling offer?', Australian Health Review, 32, pp. 423 - 438

Vonlaufen A; Phillips PA; Xu ZH; Goldstein D; Pirola RC; Wilson JS; Apte MV, 2008, 'Lending a helping hand: Role of pancreatic stellate in pancreatic cancer', Cancer Research, 68, pp. 7707 - 7710

Park SB; Krishnan AV; Lin CS; Goldstein D; Friedlander ML; Kiernan MC, 2008, 'Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies', Current Medicinal Chemistry: Cardiovascular and Hematological Agents, 15, pp. 3081 - 3094

Park SB; Lin CS-Y; Krishnan AV; Friedlander M; Goldstein D; Kiernan MC, 2008, 'Oxaliplatin-induced chronic changes in sensory nerve excitability', Clinical Neurophysiology, 119, pp. e22 - e22, http://dx.doi.org/10.1016/j.clinph.2007.10.044

Underhill CR; Goldstein D; Gorbounova VA; Biakhov MY, 2008, 'Randomized phase II trial of pemetrexed plus irinotecan (ALIRI) versus leucovorin-Modulated 5-FU plus Irinotecan (FOLFIRI) in first-line treatment of locally advanced or metastatic colorectal cancer', Oncology, 73, pp. 9 - 20

Ngan S; Fisher R; Mackay J; Solomon M; Burmeister B; Goldstein D; Schache D; Joseph D; Ackland S; McClure B, 2007, 'Acute adverse events in a randomised trial of short course versus long course preoperative radiotherapy for T3 adenocarcinoma of rectum: a Trans-Tasman Radiation Oncology Group trial (TROG 01.04)', EJC SUPPLEMENTS, 5, pp. 237 - 237, http://dx.doi.org/10.1016/S1359-6349(07)70936-9

Butow PN; Eisenbruch M; Goldstein D; Duggal-Beri P; Jefford M; Schofield P; Girgis A; King M, 2007, 'Unmet needs in Chinese, Greek and arabic speaking cancer patients in Australia', PSYCHO-ONCOLOGY, 16, pp. S77 - S78, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000249687400142&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Goldstein D; Underhill C, 2007, 'Regional cancer services in Australia: Some evidence of improvement but a long way to go', Cancer Forum, 31, pp. 67 - 69

Wilcken NR; Goldstein D; Nowak AK; Beale PJ; Jefford M; Dhillon H; O'Connell R; Heritier S; Simes RJ; Stockler M, 2007, 'A placebo-controlled trial of Sertraline's effects on symptoms, well-being and survival in advanced cancer: The ZEST Trial', Journal of Clinical Oncology, 25, pp. 9002 - 9002, http://dx.doi.org/10.1200/jco.2007.25.18_suppl.9002

Goldstein D; Shannon J; Brown C; Tebbutt N; Ackland S; Van Hazel G; Abdi E; Jefford M; Gainford MC; Adams K, 2007, 'ABC; An AGITG trial of fixed dose rate (FDR) gemcitabine (gem) and cisplatin for patients (pts) with advanced biliary tract cancer (ABC)', Journal of Clinical Oncology, 25, pp. 15015 - 15015, http://dx.doi.org/10.1200/jco.2007.25.18_suppl.15015

Schwartzberg LS; Hurwitz H; Stephenson J; Kotasek D; Goldstein D; Tebbutt N; McGreivy J; Sun Y; Yang L; Burris H, 2007, 'Safety and pharmacokinetics (PK) of AMG 706 with panitumumab plus FOLFIRI or FOLFOX for the treatment of patients (pts) with metastatic colorectal cancer (mCRC)', Journal of Clinical Oncology, 25, pp. 4081 - 4081, http://dx.doi.org/10.1200/jco.2007.25.18_suppl.4081

Leighl NB; Shepherd H; Butow P; Clarke SJ; McJannett M; Beale P; Wilcken N; Moore MJ; Chen EX; Tattersall MH; Goldstein D, 2007, 'When the goal is not cure: A randomized trial of a patient decision aid in advanced colorectal cancer', Journal of Clinical Oncology, 25, pp. 6509 - 6509, http://dx.doi.org/10.1200/jco.2007.25.18_suppl.6509

Stockler MR; O'Connell R; Nowak AK; Goldstein D; Turner J; Wilcken NR; Wyld D; Abdi EA; Glasgow A; Beale PJ; Jefford M; Dhillon H; Heritier S; Carter C; Hickie IB; Simes RJ, 2007, 'Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial', Lancet Oncology, 8, pp. 603 - 612, http://dx.doi.org/10.1016/S1470-2045(07)70148-1

Yang JL; Qu XJ; Hayes V; Brenner PC; Russell PJ; Goldstein D, 2007, 'Erlotinib (OSI-774)-induced inhibition of transitional cell carcinoma of bladder cell line growth is enhanced by interferon-alpha', British Journal of Urology, 99, pp. 1539 - 1545

Clarke S; Goldstein D; Mitchell P; Michael M; Beale P; Friedlander ML, 2007, 'Modification of leucovorin dose within a simplified FOLFOX regimen improves tolerability without compromising efficacy', Clinical Colorectal Cancer, 6, pp. 578 - 582

Bennett BK; Goldstein D; Lloyd AROLA; Friedlander ML; Hickie IB, 2007, 'The experience of cancer-related fatigue and chronic fatigue syndrome: a qualitative and comparative study', Journal of Pain and Symptom Management, 34, pp. 126 - 135

Bennett BK; Goldstein D; Friedlander ML; Hickie IB; Lloyd AR, 2007, 'The experience of cancer-related fatigue and chronic fatigue syndrome: A qualitative and comparative study', Journal of Pain and Symptom Management, 34, pp. 126 - 135

Goldstein D; Spry N; Van Hazel G; Underhill C; Kotasek D; Harvey J; Links M; Shapiro J; Iacopetta B; Australia EL, 2006, 'Combined modality therapy for pancreatic carcinoma: An Australian Pancreatic Cancer Group study of the addition of gemcitabine (G) to concurrent infusional 5-fluorouracil (CI 5FU) and 3D conformal radiotherapy (RT)-Final outcomes.', J Clin Oncol, 24, pp. 4104, http://www.ncbi.nlm.nih.gov/pubmed/27953934

Tebbutt N; Gebski V; Strickland A; Gibbs D; Walpole E; Ganju V; Goldstein D; Munro S; Harrod M; Van Hazel G, 2006, 'Randomised phase II study evaluating weekly docetaxel in combination with cisplatin and 5FU or capecitabine in metastatic oesophago-gastric cancer', Journal of Clinical Oncology, 24, pp. 4067 - 4067, http://dx.doi.org/10.1200/jco.2006.24.18_suppl.4067

Stockler MR; Heritier S; Nowak AK; Goldstein D; Turner J; Jefford M; Glasgow A; Abdi E; Beale PJ; Carter C, 2006, 'The time taken to complete quality of life questionnaires in an advanced cancer trial', Journal of Clinical Oncology, 24, pp. 8592 - 8592, http://dx.doi.org/10.1200/jco.2006.24.18_suppl.8592

Yip D; Karapetis C; Strickland A; Steer CB; Goldstein D, 2006, 'Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer.', Cochrane database of systematic reviews (Online), 3

Mitchell P; Goldstein D; Beale P; Friedlander ML; Zalcberg J; White S; Thomson JA; Clarke S; Michael M, 2006, 'Addition of Gabapentin to a Modified FOLFOX Regimen Does Not Reduce Oxaliplatin-Induced Neurotoxicity', Clinical Colorectal Cancer, 6, pp. 146 - 151

Dalton L; Luxford K; Boyle F; Goldstein D; Underhill CR; Yates P, 2006, 'An Educational Workshop Program for Rural Practitioners to Encourage Best practice for Delivery of Systemic Adjuvant Therapy', Journal of Cancer Education, 21, pp. 35 - 39

Yip D; Karapetis C; Strickland C; Steer C; Goldstein D, 2006, 'Chemotherapy and radiotherapy for pancreatic cancer', Cochrane Database of Systematic Reviews, 4

Goldstein D; Bennett BK; Friedlander ML; Davenport TA; Hickie IB; Lloyd AR, 2006, 'Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study', BMC Cancer, 6, pp. 240 - 240, http://dx.doi.org/10.1186/1471-2407-6-240

Mok KW; Goldstein D, 2006, 'Hypersensitivity reactions to oxaliplatin: Can patients be rechallenged?', Asia-Pacific Journal of Clinical Oncology, 2, pp. 175 - 179

Underhill CR; Goldstein D; Grogan PB, 2006, 'Inequity in rural cancer survival in Australia is not an insurmountable problem', Medical Journal of Australia, 6, pp. 479 - 480

Harrison ML; Goldstein D, 2006, 'Management of metastatic gastrointestinal stromal tumour in the Glivec era: a practical case-based approach', Internal Medicine Journal, 36, pp. 367 - 377

Harrison ML; Goldstein D, 2006, 'Management of metastatic gastrointestinal stromal tumour in the Glivec era: a practical case-based approach', Internal Medicine Journal, 36, pp. 367 - 377

Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2006, 'Oxaliplatin and axonal Na+ channel function in vivo', Clinical Cancer Research, 12, pp. 4481 - 4484

Goldstein D; Ackland S; Bell DR; Olver IN; Davis ID; Rosenthal M; Toner GC; Pinel MC; Byrne M, 2006, 'Phase II study of vinflunine in patients with metastatic renal cell carcinoma', Investigational New Drugs, 24, pp. 429 - 434

Grimison PS; T Chin M; Harrison ML; Goldstein D; Chin M, 2006, 'Primary pancreatic lymphoma - pancreatic tumours that are potentially curable without resection, a retrospective review of four cases', BMC Cancer, 6, pp. 117, http://dx.doi.org/10.1186/1471-2407-6-117

Shepherd LM; Goldstein D; Whitford H; Thewes B; Brummell V; Hicks M, 2006, 'The Utility of Videoconferencing to Provide Innovative Delivery of Psychological Treatment for Rural Cancer Patients: Results of a Pilot Study', Journal of Pain and Symptom Management, 32, pp. 453 - 461

Barlow-Stewart K; Yeo SS; Meiser B; Goldstein D; Tucker K; Eisenbruch M, 2006, 'Towards cultural competence in cancer genetic counselling and genetics education: lessons learned from Chinese-Australians', Genetics in Medicine, 8, pp. 24 - 32

Van Glabbeke M; Verweij J; Casali PG; Le Cesne A; Hohenberger P; Ray-Coquard I; Schlemmer M; Van Oosterom AT; Goldstein D; Sciot R; Hogendoorn PCW; Brown M; Bertulli R; Judson IR, 2005, 'Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: A European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trials Group Study', Journal of Clinical Oncology, 23, pp. 5795 - 5804, http://dx.doi.org/10.1200/JCO.2005.11.601

Yang JL; Qu XJ; Russell PJ; Goldstein D, 2005, 'Interferon-α promotes the anti-proliferative effect of gefitinib (ZD1839) on human colon cancer cell lines', Oncology, 69, pp. 224 - 238, http://dx.doi.org/10.1159/000088070

Grimison P; Goldstein D; Yeo B, 2005, 'Editor's quiz: GI snapshot. An unusual abdominal mass', Gut, 54, http://dx.doi.org/10.1136/gut.2004.051342

Burmeister B; Smithers M; Gebski V; Denham J; Devitt P; Ackland S; Findlay M; Dhillon H; Stockler M; Coates A; Matthews J; Simes J; Beller E; Fitzgerald L; Gray E; Dodds H; Marks P; Hayden P; Erratt A; Monro C; Pike R; Walpole E; Gotley D; Thomson D; Harvey J; Martin I; Burmeister E; Jamieson G; Borg M; Yeoh E; Olver I; Caruso D; Game P; Joseph D; Spry N; Minchin D; Cameron F; Faulkner K; Einhorn S; Dewar J; Gillies J; Johnson C; Kilmurray J; Neely M; Carmody M; Mackintosh J; Millar J; O'Brien P; Schwartz M; Smith R; Woods S; Nathanson L; O'Loughlin B; Grimes D; Cheuk R; Dickie G; Keller J; Archer S; Bayliss E; Gray B; Trotter J; Ransom D; Shepherd J; Stone C; Thompson I; Guiney M; Henderson M; Thomas R; Kian M; Ngan S; Rischin D; Walcher V; Zalcberg J; North J; Costello S; Perez D; Whitely D; Wyllie A; Avramovic J; Donnolly P; Fon P; Collins M; McIntosh R; Melville P; Bell R; Kirrof G; Harris I; McLennan R; Monro W; Aroney R; Falconer K; Cullingford G; Davidson A; Randell C; Berry M; Delaney G; Moylan E; Burns D; Goldstein D; Zissiadis M, 2005, 'Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: A randomised controlled phase III trial', Lancet Oncology, 6, pp. 659 - 668, http://dx.doi.org/10.1016/S1470-2045(05)70288-6

Grimison P; Goldstein D; Schneeweiss J; Murray N, 2005, 'Corticosteroid-responsive interstitial pneumonitis related to imantinib mesylate with successful rechallenge, and potential causative mechanisms', Internal Medicine Journal, 35, pp. 136 - 137, http://dx.doi.org/10.1111/j.1445-5994.2004.00757.x

Yip D; Goldstein D, 2005, 'Adding irinotecan to first-line gemcitabine improves tumour response in advanced pancreatic cancer', Cancer Treatment Reviews, 31, pp. 236 - 241

Back to profile page